Decentralized Clinical Trials (DCT)

Download this case study to learn how Castor responded to the disruptive impact of COVID-19 and helped the COVID-RED study implement decentralized clinical trial methods to recruit over 17,825 participants in just 15 weeks.

Castor and Lightship discuss the infrastructure needs for providing the best patient experience and ensuring data integrity in decentralized clinical trials.

eConsent accelerates enrollment, increases retention, and reduces site burden. Learn why it’s the way of the future for clinical trials.

Download the “Decentralized Clinical Trial Products PEAK Matrix®” assessment by Everest Group to learn why Castor is a ‘Major Contendor’ provider of decentralized clinical trial products.

Castor is using video conferencing to meet participant needs and lower site burden in clinical trials. Find 5 benefits here.

If you are planning on using eConsent in a trial, you’ll need to include it in your IRB submission. Find out what to include here.

Informed consent is a critical aspect of clinical trials. But what criteria must be met? And is there more than one type of consent? Find out here.

The future of informed consent is digital. Learn about the benefits, the process, the regulatory landscape, and the future of eConsent here.

Learn key compliance requirements, data collection tips, and important dates for the EU Medical Device Regulation in this white paper.

Castor announced continued support for the WHO Solidarity trial, the world’s largest adaptive COVID-19 trial.